ArticleFrontiers in immunology2023

Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.

Chunzhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.